Changes to RISe guidance, our upcoming public event, and more ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
@womensresearch | September 2019
June 2019 (1)

Help us spread the word about our upcoming public event!

Register today, and share our Facebook event with your friends and family.

We hope to see you there!


Research Spotlight: Gynecologic Cancer Initiative Research Excellence Cluster

Learn more about an initiative to form a Patient and Family Advisory Council for survivors of gynecologic cancers as part of the new UBC Gynecologic Cancer Initiative Research Excellence Cluster.


Tell us about your experience with emergency contraception

Contraception is a pill or device that can prevent pregnancy. Emergency Contraception is taken after condomless or non-contracepted intercourse to try and prevent pregnancy. There is an emergency contraception that is new to Canada that has been available in British Columbia since 2015 called Ella and it can only be acquired with a doctor’s prescription. There has been no previous research in Canada examining Ella since it has become available.
This project aims to:
(A) Describe the current use of Ella compared to Plan B and its equivalents since 2015, using sales and number of prescriptions
(B) Explore the experiences of Ella use as perceived by prescribers, pharmacists, and patients through interviews
If you are interested in participating, this will involve an approximately 1 hour interview. All participants will be screened for eligibility. If you are selected for an interview, you will be remunerated for your time with a $50 Amazon gift card.
For more information please email or call 604-875-2424 ext. 4685 and note you are calling about the ECElla study. If interested, please visit this link.



Nature publishes an article featuring Dr. Moe Elgendi’s research

A Q&A with Brock Williams, PhD Student

Research Spotlight: Dr. Davina Banner receives a CIHR Spring 2019 Project Grant

Dr. Wendy Norman receives a CIHR Sprint 2019 Planning and Diseemination Grant



CIHR Women’s Health Clinical Mentorship Grant 
Application Deadline: October 22nd, 2019

CIHR Planning and Dissemination Grants– Institute/Initiative Community Support
Application Deadline: September 25th, 2019

Help Health Canada bridge the gaps between research knowledge + policy development, and support the rigorous application of SGBA+ to improve health of Canadians through the CIHR
Health Policy-Research Partnerships.
Application Deadline: September 10th, 2019

Applications are open for the Heart & Stroke Research Competitions are now open!
Application Deadline: September 5th, 2019

CIHR Sex and Gender Chair
Application Deadline: October 8th, 2019

The BC Support Unit, in partnership with the Michael Smith Foundation for Health Research, are offering Pathway to Patient-Oriented Research Awards to help BC-based patient-oriented research teams pilot and test the feasibility of their research project.
LOI Deadline: September 6th, 2019

The Gynecologic Cancer Initiative-Clinical Trials Group has issued a call for proposals to support clinical research on gynecologic cancers.
Application Deadline: September 13th, 2019

Are you a member of the Fraser Health Authority? Check out awards offered by the BC SUPPORT Unit Fraser Centre.

The University of Melbourne is presenting a one-day course that provides an introduction to administrative data and data linkage at UBC Robson Square.

Perinatal Services BC's 4th Biennial Conference will be taking place February 21-22, 2020. They have issued a Call for Abstracts, open until September 6, 2019

Join us for BC Women's Hospital Research Rounds on September 20th. They will be led by Dr. Luis Nacul.

Join the UBC Women's Health Research Cluster for their inaugural Women's Health Seminar on September 23rd.

Present your research

The Origins of Child Health and Disease Works in Progress (OCHaD) group is looking for investigators and trainees to present their works in progress for their new season of OCHaD WIP seminars. 

If you or someone you know would be interested in presenting at one of our seminars, please email with your preferred seminar date from the list below.

  • Sept 11th – Room 2108, 12:00-1:00
  • Oct 9th - Room 2108, 12:00-1:00
  • Nov 13th – Room 2108, 12:00-1:00
  • Feb 12th – Room 2108, 12:00-1:00
  • Mar 11th – Room 2108, 12:00-1:00
  • Apr 8th – Room 3113, 12:00-1:00

Recent changes to RISe guidance

There have been some recent changes to the University of British Columbia’s Research Information Systems (RISe) logic around chart reviews. Here’s what PHSA’s research community should know.

PHSA supports the secondary use of identifiable patient information for research (and other purposes) when done so in a manner that is compliant with TCPS2 and FIPPA.  The following information is provided to help clarify requirements.

Section 4.8.E of the RISe guidance was recently changed and currently states that “If a retrospective chart review is retaining personal identifiers, participant consent may be required. Similarly, if a retrospective chart review is being conducted on a small set of charts, looking at rare disease, consent may be required as there is potential for participants to be identified.” In both these situations, all requests for waivers of consent must be reviewed by the Research Ethics Board (REB) which will make the final decision based on the contextual specifics of the research project.  

Waivers of consent are frequently approved by the REB for chart reviews but there are times when it might not be appropriate. Researchers who have not obtained consent from participants for secondary use of identifiable information must satisfy the REB that certain criteria have been met. The RISe system asks study teams to address each criteria as part of the consent waiver process.  The REB review process can also help study teams consider any other ethics issues that may emerge from chart reviews such as the impact that contact for consent may have on patients and consent introducing bias on the scientific integrity of your study. 

For more information we invite you to review the new BC Cancer Research Ethics Board Guidance for Chart Reviews.   


Please contact Kristie Westerlaken (BC Cancer REB manager), Jennie Prasad (BC Children’s Hospital and BC Women’s Hospital + Health Centre REB manager), or Holly Longstaff (PHSA director, Privacy & Access, Research and New Initiatives).​​